Followers | 144 |
Posts | 27707 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Tuesday, March 25, 2014 7:25:30 AM
Tuesday 25 March 2014
PETACH TIKVA, Israel, March 25, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has been invited to present at the upcoming 9th International Congress of Autoimmunity. The conference will be held on March 26-30, 2014 at Nice Acropolis Convention Center in Nice, France.
On Friday March 28th, 16:30, Can-Fite CEO Dr. Pnina Fishman will Co-Chair the session of Psoriatic Arthritis, Rheumatoid Arthritis and Ankylosing Spondylitis and deliver a presentation on: 'The A3 adenosine receptor as a therapeutic target and predictive marker in Rheumatoid Arthritis.' In the frame of the presentation Dr. Fishman will present positive data from the recently concluded Phase II Rheumatoid Arthritis and the interim analysis of the Phase II/III Psoriasis studies.
CF101 recently announced a successfully completed Phase II trial data and is set for Phase III of clinical trial testing in the U.S., Europe and Israel. Rheumatoid arthritis is an autoimmune disease and according to WebMD affects about 1% of the American population and millions more around the world. Rheumatoid arthritis is two to three times more common in women than men. According to independent business information provider Visiongain, the global rheumatoid arthritis (RA) drug market is predicted to generate revenues of $38.5 billion in 2017.
"We are excited to be a part of the conference and share our scientific findings and talk about our initiatives for the coming months and our plans for the Phase III Rheumatoid Arthritis study," says Can-Fite CEO Dr. Pnina Fishman. "Combating autoimmune diseases such as rheumatoid arthritis and developing treatments with CF101 have been our goal that is coming to fruition. The conference is a great venue to share research findings, collaborate, share best practices with our peers and learn from one another with a goal of fighting autoimmune diseases."
To arrange a one-on-one meeting with management, please contact Robert Haag at canf@irthcommunications.com or 1-866-976-4784.
About 9th International Congress On Autoimmunity
The 9th International Congress on Autoimmunity is the world's foremost gathering of top experts in immunology, rheumatology, and related fields. First established by renowned autoimmunity expert Professor Yehuda Shoenfeld, the congress will address the genetic, etiology, diagnostic, clinical aspects and novel therapies of 80 autoimmune diseases. Join your colleagues in breathtaking Nice, France, on March 26-30, 2014 and learn about the newest therapeutic techniques and diagnostic tools. Previous meetings were comprised of 81 symposia featuring 600 leading speakers.
Recent MIGI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 09:48:55 PM
- Mawson Infrastructure Group Inc. Announces Monthly Operational Update for August 2024 • GlobeNewswire Inc. • 09/16/2024 10:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 10:00:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 10:09:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 10:10:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 09:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 09:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 01:26:21 PM
- Mawson Infrastructure Group Expands to Ohio for AI/HPC Expansion • GlobeNewswire Inc. • 08/27/2024 12:50:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 12:48:56 PM
- Mawson Infrastructure Group Inc. Announces Monthly Operational Update for July 2024 • GlobeNewswire Inc. • 08/22/2024 12:50:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 12:48:25 PM
- Mawson Infrastructure Group Inc. Reports Q2 2024 Financial Results • GlobeNewswire Inc. • 08/19/2024 09:15:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 09:15:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:57:21 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:30:02 PM
- Mawson Infrastructure Group Inc. to Join World Summit AI (Artificial Intelligence) in October 2024 • GlobeNewswire Inc. • 08/14/2024 12:30:18 PM
- Mawson Infrastructure Group Inc. Expands into AI and HPC Markets and Announces the Signing of AI/HPC Colocation Agreement for 20 MW • GlobeNewswire Inc. • 08/12/2024 12:45:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:45:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 09:00:35 PM
- Mawson Infrastructure Group Inc. to Present at the 2024 Gateway Conference in San Francisco, CA • GlobeNewswire Inc. • 08/06/2024 12:45:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 09:02:41 PM
- Mawson Infrastructure Group Inc. Announces Monthly Operational Update for June 2024 • GlobeNewswire Inc. • 07/18/2024 08:53:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:46:03 PM
- Mawson Infrastructure Group Announces Several Recent New Hires to Further Drive Transformation and Growth Initiatives • GlobeNewswire Inc. • 07/17/2024 08:45:17 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM